Joseph S Fernandez-Moure1, Jeffrey L Van Eps1, Zachary K Menn2, Fernando J Cabrera3, Ennio Tasciotti3, Bradley K Weiner4, Warren A Ellsworth5. 1. Department of Surgery, Houston Methodist Hospital, Houston, Texas; Surgical Advanced Technologies Laboratory, Department of Regenerative Medicine, Houston Methodist Research Institute, Houston, Texas. 2. Department of Plastic Surgery, Houston Methodist Hospital, Houston, Texas. 3. Surgical Advanced Technologies Laboratory, Department of Regenerative Medicine, Houston Methodist Research Institute, Houston, Texas. 4. Department of Surgery, Houston Methodist Hospital, Houston, Texas; Department of Orthopedic Surgery, Houston Methodist Hospital, Houston, Texas. Electronic address: BKWeiner@houstonmethodist.org. 5. Department of Surgery, Houston Methodist Hospital, Houston, Texas; Department of Plastic Surgery, Houston Methodist Hospital, Houston, Texas.
Abstract
BACKGROUND: High recurrence rates because of poor tissue incorporation limit the use of acellular dermal matrices (ADMs) in ventral hernia repair (VHR). Platelet rich plasma (PRP) is a growth factor-rich autologous blood product known to enhance tissue repair through cellular proliferation and neovascularization. We sought to study the effect of PRP on a porcine noncross-linked ADM in an in vivo model of VHR. We hypothesized that PRP would enhance ADM-tissue incorporation in a rat model of VHR. METHODS: Whole blood was extracted from Lewis rats followed by PRP isolation and characterization. Using a rat model of VHR, a noncross-linked ADM (Strattice) was implanted and activated PRP applied before closure. Rats were sacrificed at 2, 4, and 6 wk. Immunohistochemical staining of CD 31 on endothelial cells was used to quantify neovascularization. Hematoxylin eosin stained tissues were measured to quantify tissue deposition. RESULTS: Platelet concentration of PRP was standardized to 1 × 10(6) platelets/μL. Grossly, vessels were more evident in PRP-treated rats. Immunohistochemical analysis demonstrated neovascularization was significantly greater in the PRP-treated ADMs at all time points. This increase in neovascularization correlated with an increased thickness of tissue deposition at 4 and 6 wk. CONCLUSIONS: PRP enhanced neovascularization and incorporation in a rat model of VHR. Enhanced neovascularization was associated with earlier and greater tissue deposition on the ADM. This suggests that PRP could be used as an adjunct to VHR in clinical scenarios where poor wound healing is anticipated and enhanced neovascularization and early tissue deposition are desired.
BACKGROUND: High recurrence rates because of poor tissue incorporation limit the use of acellular dermal matrices (ADMs) in ventral hernia repair (VHR). Platelet rich plasma (PRP) is a growth factor-rich autologous blood product known to enhance tissue repair through cellular proliferation and neovascularization. We sought to study the effect of PRP on a porcine noncross-linked ADM in an in vivo model of VHR. We hypothesized that PRP would enhance ADM-tissue incorporation in a rat model of VHR. METHODS: Whole blood was extracted from Lewis rats followed by PRP isolation and characterization. Using a rat model of VHR, a noncross-linked ADM (Strattice) was implanted and activated PRP applied before closure. Rats were sacrificed at 2, 4, and 6 wk. Immunohistochemical staining of CD 31 on endothelial cells was used to quantify neovascularization. Hematoxylin eosin stained tissues were measured to quantify tissue deposition. RESULTS: Platelet concentration of PRP was standardized to 1 × 10(6) platelets/μL. Grossly, vessels were more evident in PRP-treated rats. Immunohistochemical analysis demonstrated neovascularization was significantly greater in the PRP-treated ADMs at all time points. This increase in neovascularization correlated with an increased thickness of tissue deposition at 4 and 6 wk. CONCLUSIONS:PRP enhanced neovascularization and incorporation in a rat model of VHR. Enhanced neovascularization was associated with earlier and greater tissue deposition on the ADM. This suggests that PRP could be used as an adjunct to VHR in clinical scenarios where poor wound healing is anticipated and enhanced neovascularization and early tissue deposition are desired.
Authors: Maria S Altieri; Gabriel Pagnotti; Angelique Corthals; Kenneth Shroyer; Aurora D Pryor; Mark Talamini; Dana A Telem Journal: Surg Endosc Date: 2016-12-06 Impact factor: 4.584
Authors: Ann-Kathrin Börger; Dorothee Eicke; Christina Wolf; Christiane Gras; Susanne Aufderbeck; Kai Schulze; Lena Engels; Britta Eiz-Vesper; Axel Schambach; Carlos A Guzman; Nico Lachmann; Thomas Moritz; Ulrich Martin; Rainer Blasczyk; Constança Figueiredo Journal: Mol Med Date: 2016-05-16 Impact factor: 6.354
Authors: Joseph S Fernandez-Moure; Jeffrey L Van Eps; Jacob C Scherba; Seth Haddix; Megan Livingston; Nathan S Bryan; Concepcion Cantu; Chandni Valson; Francesca Taraballi; Lewis J Kaplan; Randall Olsen; Ennio Tasciotti Journal: Surg Infect (Larchmt) Date: 2021-04-30 Impact factor: 1.853
Authors: Joseph S Fernandez-Moure; Jeffrey L Van Eps; Jessica R Rhudy; Fernando J Cabrera; Ghanashyam S Acharya; Ennio Tasciotti; Jason Sakamoto; Joan E Nichols Journal: J Tissue Eng Date: 2016-02-01 Impact factor: 7.813